Best practices in the treatment of neuropathic pain.

Pain Manag

Department of Anesthesia & Critical Care, University of Chicago, 5841 S Maryland Avenue, Chicago, IL 60637, USA.

Published: November 2013

SUMMARY Neuropathic pain is a complex pain syndrome that remains difficult to treat. Patients fail to obtain satisfactory relief despite receiving pharmacological agents. Neuropathic pain has a significant impact on health-related quality of life. A multidisciplinary approach is recommended in the treatment of neuropathic pain. Preventative, nonpharmacological and pharmacological treatments are suggested in the management of neuropathic pain. Interventional options, such as spinal cord stimulation, intrathecal drug delivery, intravenous infusions therapies, and sympathetic nerve block, should be considered in patients with refractory neuropathic pain.

Download full-text PDF

Source
http://dx.doi.org/10.2217/pmt.13.50DOI Listing

Publication Analysis

Top Keywords

neuropathic pain
20
treatment neuropathic
8
pain
7
neuropathic
5
best practices
4
practices treatment
4
pain summary neuropathic
4
summary neuropathic pain
4
pain complex
4
complex pain
4

Similar Publications

Microvascular decompression is considered a first-line treatment in classical trigeminal neuralgia. Teflon is the material commonly used. The use of autologous muscle has been occasionally reported.

View Article and Find Full Text PDF

This case series aimed to assess the treatment outcomes of onabotulinum toxin A (BTX-A) in patients with refractory posttraumatic trigeminal neuropathic pain (PTNP) and to conduct a narrative review of the evidence for BTX-A in PTNP. Thirteen patients were treated with BTX-A infiltrations. Patient demographic and pain characteristics, BTX-A administration, and treatment outcomes were retrospectively analyzed.

View Article and Find Full Text PDF

Bugs take the sting out.

Cell Host Microbe

January 2025

Department of Biological Chemistry, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address:

Jiang et al. investigate the role of the microbiota in postherpetic neuralgia (PHN), a chronic pain condition resulting from varicella-zoster virus reactivation. They identify microbiome alterations in PHN patients, linking microbes and pain sensitivity.

View Article and Find Full Text PDF

Maladaptive changes in the homeostasis of AEA-TRPV1/CB1R induces pain-related hyperactivity of nociceptors after spinal cord injury.

Cell Biosci

January 2025

State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200438, People's Republic of China.

Background: Neuropathic pain resulting from spinal cord injury (SCI) is associated with persistent hyperactivity of primary nociceptors. Anandamide (AEA) has been reported to modulate neuronal excitability and synaptic transmission through activation of cannabinoid type-1 receptors (CB1Rs) and transient receptor potential vanilloid 1 (TRPV1). However, the role of AEA and these receptors in the hyperactivity of nociceptors after SCI remains unclear.

View Article and Find Full Text PDF

Understanding the Physiopathology of Pain Pathways for a Practical Approach of Cancer Pain Management.

Cardiovasc Intervent Radiol

January 2025

Clinique de la Douleur., Hôpital de La Tour, Geneva, Suisse.

Pain associated with cancer is often the first symptom reported with major repercussions on patient's quality of life. Mechanical compression, release of algogenic substances by the tumor or the complications of oncologic treatment represent the major causes. Nociceptive and neuropathic pain are both induced by different mediators that give rise to a neuroinflammation creating a peripheral and central sensitization responsible of chronic pain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!